✦ LIBER ✦

HER-2 and choice of adjuvant chemotherapy in breast cancer

✍ Scribed by Soonmyung Paik; Chanheun Park

Book ID: 114105344
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 433 KB
Volume: 28
Category: Article
ISSN: 0093-7754
DOI: 10.1016/s0093-7754(01)90127-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab after Adjuvant Chemotherapy

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

✍ Piccart-Gebhart, Martine J.; Procter, Marion; Leyland-Jones, Brian; Goldhirsch, 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 149 KB

2–47 Trastuzumab After Adjuvant Chemothe

2–47 Trastuzumab After Adjuvant Chemotherapy in HER2-Positive Breast Cancer

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

4–58 HER2 and Responsiveness of Breast C

4–58 HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

✍ Hayes, D.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Trastuzumab plus Adjuvant Chemotherapy f

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

✍ Romond, Edward H.; Perez, Edith A.; Bryant, John; Suman, Vera J.; Geyer, Charles 📂 Article 📅 2005 🏛 Massachusetts Medical Society 🌐 English ⚖ 162 KB

Adjuvant therapy of HER2+breast cancer

✍ EP Winer 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 461 KB

2–46 Trastuzumab Plus Adjuvant Chemother

2–46 Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB